+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A new cause of progressive intrahepatic cholestasis: 3 beta-hydroxy-C27-steroid dehydrogenase/isomerase deficiency



A new cause of progressive intrahepatic cholestasis: 3 beta-hydroxy-C27-steroid dehydrogenase/isomerase deficiency



Journal of Pediatrics 125(3): 379-384



There have been a few reports of infants with severe neonatal cholestasis related to a defect in primary bile acid synthesis. To assess the importance of such deficiency among children with progressive intrahepatic cholestasis (Byler disease), screening for inborn errors in bile acid synthesis was performed by fast atom bombardment ionization-mass spectrometry of urine samples from 30 affected children. Bile acid analysis revealed a specific fast atom bombardment ionization-mass spectrometry profile for 3 beta-hydroxy-C27 steroid dehydrogenase/isomerase deficiency in five children who had jaundice, hepatosplenomegaly, and fatty stools beginning at ages ranging from 4 to 46 months. None of them had pruritus. Liver function tests showed persistently normal serum gamma-glutamyltransferase activity, low serum cholesterol and vitamin E levels, normal serum bile acid concentrations despite raised serum bilirubin levels, and decreased prothrombin time and clotting factor V. In four of the cases a similar disease was observed in siblings. Liver function returned to normal after oral ursodeoxycholic acid therapy. We conclude that 3 beta-hydroxy-C27-steroid dehydrogenase/isomerase deficiency should be considered when idiopathic cholestatic liver disease with clinical features akin to Byler disease is characterized by the association of normal serum gamma-glutamyltransferase activity, normal serum bile acid concentration, absence of pruritus, and a return to normal liver function during ursodeoxycholic acid therapy. Early identification of these children is essential because they benefit from bile acid therapy and might thus avoid the need for liver transplantation.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 045079307

Download citation: RISBibTeXText

PMID: 7915305


Related references

Progressive intrahepatic cholestasis with normal gamma-glutamyltransferase is highly associated with the 3-beta-hydroxysteroid dehydrogenase/isomerase deficiency, an inborn error in bile acid synthesis A new category of metabolic liver disease. Hepatology 18(4 Part 2): 178A, 1993

3 beta hydroxy steroid dehydrogenase isomerase activity in placentas from pregnancies complicated by steroid sulfatase deficiency. Journal of Steroid Biochemistry 13(5): 475-480, 1980

Affinity alkylation of human placental 3 beta hydroxy 5 ene steroid dehydrogenase and steroid 5 4 ene isomerase by 2 alpha bromoacetoxyprogesterone evidence for separate dehydrogenase and isomerase sites on one protein. Journal of Steroid Biochemistry 36(1-2): 117-124, 1990

3-beta-Hydroxysteroid dehydrogenase deficiency in children A new cause of progressive intrahepatic cholestasis with normal serum gamma-glutamyltransferase activity. Journal of Hepatology 18(Suppl. 1): S3, 1993

Testicular 3 beta hydroxy steroid dehydrogenase deficiency in 3 beta hydroxy steroid dehydrogenase form of congenital adrenal hyperplasia. Pediatric Research: 332-104, 1973

Congenital disorders of the bile acid metabolism (3 beta-hydroxy-delta 5-steroid dehydrogenase/isomerase deficiency, delta 4-3-oxosteroid 5 beta-reductase deficiency, cerebrotendinous xanthomatosis, and peroxisomal disorders. Ryoikibetsu Shokogun Shirizu 1995(8): 362-366, 1995

An infant with 3 beta-hydroxy-delta 5-C27-steroid dehydrogenase/isomerase deficiency presenting with typical neonatal hepatitis syndrome: the first Japanese case. Acta Paediatrica Japonica 40(6): 638-640, 1998

Solubilization of delta 5 3 beta hydroxy steroid dehydrogenase ec 1.1.1.51 with delta 5 delta 4 isomerase ec 5.3.3.1 and 17 beta hydroxy steroid dehydrogenase ec 1.1.1.64 from rat testicular microsomal fraction by several detergents. Journal of Steroid Biochemistry 16(4): 587-593, 1982

Detection of 3 alpha hydroxy 5 beta steroid dehydrogenase 3 beta hydroxy 5 beta steroid dehydrogenase and 17 beta hydroxy 5 beta steroid dehydrogenase in epididymal spermatozoa of holstein bulls. Journal of Reproduction & Fertility 38(1): 59-64, 1974

In vitro metabolism of 4 pregnenes in ovaries of a fresh water teleost the ayu plecoglossus altivelis production of 17 alpha 20 beta di hydroxy 4 pregnen 3 one and its 5 beta reduced metabolites and activation of 3 beta hydroxy steroid dehydrogenase and 20 beta hydroxy steroid dehydrogenase by treatment with a fish gonadotropin. General & Comparative Endocrinology 45(4): 473-481, 1981

Affinity alkylation of human placental 3b -hydroxy-5-ENE-steroid dehydrogenase and steroid 54-ene-isomerase by 2a-bromoacetoxyprogesterone: Evidence for separate dehydrogenase and isomerase sites on one protein. Journal of Steroid Biochemistry 36(1-2): 117-123, 1990

The bile acid synthetic gene 3beta-hydroxy-Delta(5)-C(27)-steroid oxidoreductase is mutated in progressive intrahepatic cholestasis. Journal of Clinical Investigation 106(9): 1175-1184, 2000

Effects of bezafibrate on dyslipidemia with cholestasis in children with familial intrahepatic cholestasis-1 deficiency manifesting progressive familial intrahepatic cholestasis. Metabolism: Clinical and Experimental 58(1): 48-54, 2009

Comparative study of activity of 3 beta hydroxy steroid dehydrogenase and 17 beta hydroxy steroid dehydrogenase of the ovary and the steroid plasma content in hybrid ducks pekin male barbary female. Cellular and Molecular Biology 22(3-4): 293-300, 1977

Histochemistry of the 3 beta hydroxy steroid dehydrogenase ec 1.1.1.51 17 beta hydroxy steroid dehydrogenase ec 1.1.1.53 and 3 alpha hydroxy steroid dehydrogenase ec 1.1.1.50 in human salivary glands. Archives of Oral Biology 27(7): 547-552, 1982